ArticleParasitology research2025

Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers.

Paula Ximena Pavia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.